Originally posted by the Voice of America.
Voice of America content is produced by the Voice of America,
a United States federal government-sponsored entity, and is in
the public domain.


Partners Pfizer, BioNTech Seek Emergency Vaccine Authorization From FDA

VOA News

   Pharmaceutical company Pfizer and its German partner, BioNTech, said
   Friday they have filed for emergency authorization from the U.S. Food
   and Drug Administration (FDA) to use their COVID-19 vaccine, saying
   they are poised to begin distribution within hours after authorization.

   The application comes after the companies said testing shows the
   vaccine has an effectiveness rate of 95 percent, with no serious safety
   concerns observed to date.

   In a news release, the companies say in addition to their submission to
   the FDA, they are seeking authorization from authorities in Australia,
   Canada, Europe, Japan and the U.K., and plan to submit applications
   immediately to other regulatory agencies around the world.

.